263 related articles for article (PubMed ID: 31589557)
1. Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.
Gudin J; Fudin J; Wang E; Haylon T; Patel K; Goss TF
J Manag Care Spec Pharm; 2019 Dec; 25(12):1387-1396. PubMed ID: 31589557
[TBL] [Abstract][Full Text] [Related]
2. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Puenpatom RA; Ben-Joseph RH; Summers KH
J Med Econ; 2010; 13(3):482-91. PubMed ID: 20684669
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.
Honda M; Murata T; Ebata N; Fujii K; Ogawa S
J Dermatol; 2017 Jul; 44(7):767-773. PubMed ID: 28256737
[TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
5. Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies.
Ngo AL; Urits I; Yilmaz M; Fortier L; Anya A; Oh JH; Berger AA; Kassem H; Sanchez MG; Kaye AD; Urman RD; Herron EW; Cornett EM; Viswanath O
Adv Ther; 2020 May; 37(5):2003-2016. PubMed ID: 32297285
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing and managing postherpetic neuralgia.
Nalamachu S; Morley-Forster P
Drugs Aging; 2012 Nov; 29(11):863-9. PubMed ID: 23038608
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
Ritchie M; Liedgens H; Nuijten M
Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
[TBL] [Abstract][Full Text] [Related]
8. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
[TBL] [Abstract][Full Text] [Related]
9. Review of current guidelines on the care of postherpetic neuralgia.
Argoff CE
Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
[TBL] [Abstract][Full Text] [Related]
10. Postherpetic neuralgia: New hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch.
Gawecka E; Viken O
Scand J Pain; 2012 Oct; 3(4):220-228. PubMed ID: 29913873
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
Roland CL; Ye X; Stevens V; Oderda GM
J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
[TBL] [Abstract][Full Text] [Related]
12. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
13. Management of herpes zoster (shingles) and postherpetic neuralgia.
Johnson RW; Whitton TL
Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
Liedgens H; Hertel N; Gabriel A; Nuijten M; Dakin H; Mitchell S; Nautrup BP
Clin Drug Investig; 2008; 28(9):583-601. PubMed ID: 18666805
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
Dakin H; Nuijten M; Liedgens H; Nautrup BP
Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
[TBL] [Abstract][Full Text] [Related]
16. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.
Hempenstall K; Nurmikko TJ; Johnson RW; A'Hern RP; Rice AS
PLoS Med; 2005 Jul; 2(7):e164. PubMed ID: 16013891
[TBL] [Abstract][Full Text] [Related]
17. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin.
Johnson P; Becker L; Halpern R; Sweeney M
Clin Drug Investig; 2013 Jan; 33(1):35-44. PubMed ID: 23179473
[TBL] [Abstract][Full Text] [Related]
18. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Brixner D; Rubin DT; Mease P; Mittal M; Liu H; Davis M; Ganguli A; Fendrick AM
J Manag Care Spec Pharm; 2019 Jul; 25(7):770-779. PubMed ID: 31081461
[TBL] [Abstract][Full Text] [Related]
19. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
